Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Androxy (fluoxymesterone) and Testopel (testosterone) are both used to treat low testosterone in males, but they have some key differences. Androxy, an androgen, was available in oral form and also used to treat breast cancer in females, but it has been discontinued in the United States. On the other hand, Testopel is a testosterone replacement therapy available as an implantable pellet, which is placed under the skin by a healthcare provider. Testopel is long-acting, requiring implantation every 3 to 6 months, whereas Androxy was taken orally. Additionally, Testopel is not recommended for men with breast or prostate cancer, while Androxy was used to slow the spread of metastatic breast cancer in females. Testopel also has specific risks related to the implantation procedure, such as infection and pellet extrusion, which are not concerns with the discontinued oral Androxy.
Androxy (fluoxymesterone)
Testopel (testosterone pellets)
Androxy (fluoxymesterone)
Testopel (testosterone pellets)
Summary of Fluoxymesterone vs. Testopel
Summary for Androgen
Androxy (fluoxymesterone) is a medication used for treating conditions caused by low testosterone in males. It is also used to treat breast cancer in females. Androxy (fluoxymesterone) is no longer available in the United States because it was discontinued.
Summary for Testosterone replacement
Prescription only
Testopel (testosterone pellets) is an implantable pellet medication used as long-acting testosterone replacement therapy. It treats certain males with low testosterone and delayed puberty. The pellets are implanted, or placed under your skin, by a healthcare professional (HCP) typically every 3 to 6 months. Side effects include pain and swelling at the implantation site, as well as sexual side effects like more frequent erections and changes in sex drive.